TrialBMJ (Clinical research ed.)2022

Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive, multicentre, phase 3, randomised controlled trial.

Meg J Jardine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.